ADVFN Logo

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

SYRS Syros Pharmaceuticals Inc

5,30
-0,54 (-9,25%)
29 Mär 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Syros Pharmaceuticals Inc SYRS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,54 -9,25% 5,30 00:29:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,58 5,15 5,8999 5,35 5,84
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
27.3.202412:30BWSyros Reports Fourth Quarter and Full Year 2023 Financial..
27.3.202411:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
25.3.202412:00BWSyros Announces Completion of Enrollment of 190 Patients..
20.3.202412:00BWSyros to Report Fourth Quarter and Full Year 2023 Financial..
27.2.202413:00BWSyros to Participate in TD Cowen 44th Annual Health Care..
15.2.202402:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202402:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202401:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202400:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.1.202413:06EDGAR2Form 8-K - Current report
08.1.202413:00BWSyros Highlights Anticipated 2024 Milestones to Deliver on..
02.1.202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26.12.202323:19EDGAR2Form SC 13D/A - General statement of acquisition of..
19.12.202322:59EDGAR2Form 8-K - Current report
19.12.202322:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19.12.202313:27BWSyros Announces Pricing of $45.0 million Underwritten..
14.12.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:12EDGAR2Form 144 - Report of proposed sale of securities
08.12.202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202322:00EDGAR2Form 144 - Report of proposed sale of securities
06.12.202313:05EDGAR2Form 8-K - Current report
06.12.202313:00BWSyros Announces Encouraging Initial Data from Randomized..
05.12.202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202313:30BWSyros to Participate in Upcoming Investor Conferences
14.11.202313:30BWSyros Reports Third Quarter 2023 Financial Results and..
14.11.202312:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:30BWSyros to Report Third Quarter 2023 Financial Results on..
02.11.202321:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202321:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202322:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
02.10.202314:49EDGAR2Form 8-K - Current report
02.10.202314:45BWSyros Announces Planned CEO Leadership Transition and..
07.9.202322:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
11.8.202322:30EDGAR2Form 8-K - Current report
08.8.202313:30BWSyros Reports Second Quarter 2023 Financial Results and..
08.8.202312:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04.8.202322:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
02.8.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202313:30BWSyros to Report Second Quarter 2023 Financial Results on..
31.7.202322:12EDGAR2Form 144 - Report of proposed sale of securities
21.7.202322:36EDGAR2Form 8-K - Current report
19.7.202302:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.7.202322:00EDGAR2Form 144 - Report of proposed sale of securities
05.7.202322:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
08.6.202313:30BWSyros to Present at Sidoti June 2023 Virtual Small-Cap..
01.6.202322:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
25.5.202323:05BWSyros Presents Data from Phase 1/1b Clinical Trial of..
10.5.202313:30BWSyros Reports First Quarter 2023 Financial Results and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock